Fundraising Fox

Long Bridge Medical

South San Francisco, US · Founded 2019 · Delaware corporation

Long Bridge Medical is developing the LensOne platform, a prosthetic capsular bag that provides stable, centered fixation of intraocular lenses (IOLs) in eyes lacking adequate capsular support and unsuited to anterior chamber IOLs. The investigational ophthalmic device targets surgeons treating IOL dislocation and secondary lens implantation.

Founders & leadership

MC
Matthew ClarkeExecutive
AN
Ayman NaseriNamed on SEC filing
DF
David F ChangNamed on SEC filing
ED
Eugene de Juan Jr., MDNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$7.2M disclosed across 3 rounds · 2023–2025

$2.5MraisedAug 2026 · 29 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ayman NaseriExecutive Officer, Director
  • Matthew ClarkeExecutive Officer
  • David F ChangDirector
  • Eugene de Juan Jr., MDDirector
Offering amount
$5M
Amount sold
$2.5M
First sale
Dec 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1000KraisedMar 2025 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew ClarkeExecutive Officer
  • Ayman NaseriExecutive Officer, Director
Offering amount
$1000K
Amount sold
$1000K
First sale
Nov 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3.6MraisedNov 2023 · 33 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ayman NaseriExecutive Officer, Director
Offering amount
$4.9M
Amount sold
$3.6M
First sale
Oct 2023
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

What does Long Bridge Medical do?
Long Bridge Medical is developing the LensOne platform, a prosthetic capsular bag that provides stable, centered fixation of intraocular lenses (IOLs) in eyes lacking adequate capsular support and unsuited to anterior chamber IOLs. The investigational ophthalmic device targets surgeons treating IOL dislocation and secondary lens implantation.
How much funding has Long Bridge Medical raised?
Long Bridge Medical has disclosed $7.2M raised across 3 rounds.
Where is Long Bridge Medical headquartered?
Long Bridge Medical is headquartered in South San Francisco, US.